Organization, Nature of Business, and Liquidity (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) Women Segment	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Organization and Nature of Business [Abstract]
Number of operating segments | Segment	1
Number of women used FemBloc for permanent birth control	401
Number of year where women's used for permanent birth control.	1 year
Number of women enrolled for a clinical readout	50
Number of women need to use for interim analysis of clinical data for permanent birth control	300
Period for analysis of clinical data for permanent birth control	1 year
Follow-up period for interim analysis of clinical data for permanent birth control	5 years
Liquidity [Abstract]
Cash and cash equivalents | $	$ 17,835,968		$ 21,716,077
Net loss | $	$ (3,599,510)	$ (2,946,257)